Innogenetics

Innogenetics

Fujirebio - a long history of pioneering in vitro diagnostics (IVD) solutions.

Launch date
Employees
Market cap
-
Enterprise valuation
AUD341m (Public information from Sep 2008)
Ghent East Flanders (HQ)
  • Edit
DateInvestorsAmountRound

N/A

Spinout

€8.0m

Late VC

€169m

Valuation: €201m

Acquisition
Total FundingAUD13.6m

Recent News about Innogenetics

Edit

Investments by Innogenetics

Edit
Cepheid
ACQUISITION by Danaher Sep 2016
CellTran
ACQUISITION by York Pharma Oct 2008